Selectivity release of the type ii decoy il-1 receptor

Cytokine

Volumn 12, Issue 7, 2000, Pages 1001-1006

  Orlando, Simone ^a   Polentarutti, Nadia ^a   Mantovani, Alberto ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

IL 1 decoy receptor; Shedding; Soluble receptors

Indexed keywords

CHEMOATTRACTANT; COMPLEMENTARY DNA; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; PHORBOL ESTER;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 0033926664     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0601     Document Type: Article

References (39)

1. Dinarello CA (1989) Interleukin-1 and its biologically related cytokines. Adv Immunol 44:153-191.
2. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
3. Colotta F, Dower SK, Sims JE, Mantovani A (1994) The type II 'decoy' receptor as a novel regulatory pathway of the Interleukin-1 system. Immunol Today 15:562-566.
4. Arend WP (1993) Interleukin-1 receptor antagonist. Adv Immunol 54:167-227.
5. Muzio M, Polentarutti N, Sironi M, Poli G, De Gioia L, Introna M, Mantovani A, Colotta F (1995) Cloning and characterization of a new isoform of the interleukin-1 (IL-1) receptor antagonist (IL-1ra). J Exp Med 182:623-628.
6. Sims JE, March CJ, Cosman D, Widmer MB, MacDonald HR, McMahan CJ, Grubin C E, Wignall JM, Jackson JL, Call SM, Friend D, Alpert AR, Gillis S, Urdal DL, Dower SK (1988) CDNA espression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241:585-589.
7. McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Brannan CI (1991) A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10:2821-2832.
8. Chizzonite R, Truitt T, Kilian PL, Stern AS, Nunes P, Parker KP, Kaffka KL, Chua AO, Lugg DK, Gubler U (1989) Two high-affinity interleukin 1 receptors represent separate gene products. Proc Natl Acad Sci USA 86:8029-8033.
9. Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite R, Ju G (1995) Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 270:13757-13765.
10. Korherr C, Hofmeister R, Wesche H, Falk W (1997) A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur J Immunol 27:262-267.
11. Muzio M, Ni J, Feng P, Dixit V (1997) A novel IRAK/Pelle family member (IRAK-2) and MyD88 as proximal mediators of interleukin-1 signaling. Science 278:1612-1615.
12. Yoon DY, Dinarello CA (1998) Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein. J Immunol 160:3170-3179.
13. Huang J, Gao X, Li S, Cao Z (1997) Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci USA 94:12829-12832.
14. Hofmeister R, Wiegmann K, Korherr C, Bernardo K, Kronke M, Falk W (1997) Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J Biol Chem 272:27730-27736.
15. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein KH, Dower SK (1993) Interleukin-1 signaling may occur exclusively via the type I receptor. Proc Natl Acad Sci USA 90:6155-6159.
16. McKean DJ, Podzorski RP, Bell MP, Nilson AE, Huntoon CJ, Slack J, Dower SK, Sims JE (1993) Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity. J Immunol 151:3500-3510.
17. Stylianou E, O'Neill LA, Rawlinson L, Edbrooke MR, Woo P, Saklatvala J (1992) Interleukin-1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. J Biol Chem 267:15836-15841.
18. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A (1993) Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472-475.
19. Re F, Sironi M, Muzio M, Matteucci C, Introna M, Orlando S, Penton-Rol G, Dower SK, Sims JE, Colotta F, Mantovani A (1996) Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface receptor with anti-interleukin-1 function. J Exp Med 183:1841-1850.
20. Penton Rol G, Polentarutti N, Sironi M, Saccani S, Introna M, Mantovani A (1997) Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a myelomonocytic cellular context dampens the response to interleukin-1. Eur Cytokine Netw 8:265-269.
21. Barak V, Nisman B, Polliack A, Vannier E, Dinarello CA (1998) Correlation of serum level of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia. Eur Cytokine Netw 9:33-39.
22. van Deuren M, van der-Jongekrijg J, Vannier E, van Dalen R, Pesman G, Bartelink AKM, Dinarello CA, van der Meer JWM (1997) The pattern of interleukin-1β (IL-1β) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II i acute meningococcal infections. Blood 90:1101-1108.
23. Giri JG, Wells J, Dower SK, McCall CE, Guzman RN, Slack J, Bird TA, Shanebeck K, Grabstein KH, Sims JE, Alderson MR (1994) Elevated levels of shed type II IL-1 receptor in sepsis; potential role for type II receptor in regulation of IL-1 responses. J Immunol 153:5802-5809.
24. Pruitt JH, Burress Welborn M, Edwards PD, Harward TRS, Seeger JW, Martin TD, Smith C, Kenney JA, Wesdorp RIC, Meijer S, Cuesta MA, Abouhanze A, Copeland III EM, Giri J, Sims JE, Moldaver LL, Oldenburg HSA (1996) Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87:3282-3288.
25. Einstein R, Jackson JR, D'Alessio K, Lillquist JS, Sathe G, Porter T, Young P (1996) Type I IL-1 receptor: ligand specific conformation differences and the role of glycosilation in ligand binding. Cytokine 8:206-213.
26. Svenson M, Nedergaard S, Heegaard PMH, Whisenand TD, Arend WP, Bendtzen K (1995) Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors. Eur J Immunol 25: 2842-2850.
27. Estrov HZ, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D, Gutterman JU, Talpaz M (1991) Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity. Blood 78:1476-1484.
28. Estrov HZ, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D, Gutterman JU, Talpaz M (1992) Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. Blood 79:1938-1945.
29. Preas II HL, Reda D, Tropea M, Vandivier RW, Banks SM, Agosti JM, Sufredini AF (1997) Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxin. Blood 88:2465-2472.
30. Svenson MM, Hansen MB, Heegaard P, Abell K, Bendtzen K (1993) Specific binding of interleukin 1 (IL-1) β and IL-1 receptor antagonist (IL-1ra) to human serum. High affinity binding of IL-1ra to soluble IL-1 receptor type I. Cytokine 5:427-435.
31. Re F, Muzio M, De Rossi M, Polentarutti N, Giri JG, Mantovani A, Colotta F (1994) The type II receptor as a decoy target for interleukin-1 in polymorphonuclear leukocytes: characterization of induction by dexametasone and ligand binding properties of the released decoy receptor. J Exp Med 179:739-743.
32. Colotta F, Re F, Muzio M, Polentarutti N, Minty A, Caput D, Ferrara P, Mantovani A (1994) Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J Biol Chem 269:12403-12406.
33. Colotta F, Saccani S, Giri JG, Dower SK, Sims JE, Introna M, Mantovani A (1996) Regulated expression and release of the interleukin 1 decoy receptor in human mononuclear phagocytes. J Immunol 156:2534-2541.
34. Colotta F, Orlando S, Fadlon EJ, Sozzani S, Matteucci C, Mantovani A (1995) Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J Exp Med 181:2181-2188.
35. Orlando S, Matteucci C, Fadlon EJ, Buurman WA, Bardella MT, Colotta F, Introna M, Mantovani A (1997) TNFα, unlike other pro- and anti-inflammatory cytokines induce rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells. J Immunol 158:3861-3868.
36. Sambo P, Fadlon EJ, Sironi M, Matteucci C, Introna M, Mantovani A, Colotta F (1996) Reactive oxygen intermediates cause rapid release of the interleukin-1 decoy receptor from human myelomonocytic cells. Blood 87:1682-1686.
37. Orlando S, Sironi M, Bianchi G, Drummond AH, Boraschi D, Yabes D, Colotta F, Mantovani A (1997) Role of Metalloproteases in the Release of the IL-1 Type II Decoy Receptor. J Biol Chem 272:31764-31769.
38. Rauschmayr T, Groves RW, Kupper TS (1997) Keratinocyte expression of the type II interleukin 1 receptor mediates local and specific inhibition of interleukin 1 mediated inflammation. Proc Natl Acad Sci USA 94:5814-5819.
39. Penton-Rol G, Orlando S, Polentarutti N, Bernasconi S, Muzio M, Introna M, Mantovani M (1999) Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant upregulation of the type I receptor and induction of incompletely spliced transcripts. J Immunol 162:2931-2938.